Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hydrochloride, Medetomidine
2. Levomedetomidine
3. Medetomidine Hydrochloride
4. Mpv 785
5. Mpv-785
6. Mpv785
1. 86347-14-0
2. 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole
3. Medetomidina
4. Medetomidinum
5. Medetomidinum [latin]
6. Medetomidina [spanish]
7. 4-[1-(2,3-dimethylphenyl)ethyl]-1h-imidazole
8. 5-[1-(2,3-dimethylphenyl)ethyl]-1h-imidazole
9. (+-)-4-(alpha,2,3-trimethylbenzyl)imidazole
10. 1h-imidazole, 4-[1-(2,3-dimethylphenyl)ethyl]-
11. Mr15e85mqm
12. Chembl77921
13. Chebi:48552
14. Medetomidine (inn)
15. Medetomidine [inn]
16. Dexmedetomidina
17. 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-
18. Medetomidine [inn:ban]
19. (+)-(s)-4-[1-(2,3-dimethylphenyl) Ethyl]-1h -imidazole Monohydrochloride
20. Unii-mr15e85mqm
21. Domtor
22. Mfcd00880557
23. (rs)-4-(alpha,2,3-trimethylbenzyl)imidazol
24. Medetomidine [mi]
25. Domitor [veterinary] (tn)
26. Schembl26432
27. Dtxsid6048258
28. Medetomidine [green Book]
29. Hms3651h20
30. (s)-medetomidine; Dexmedetomidinum
31. Bcp06913
32. Bcp12592
33. Bdbm50036913
34. Mfcd00864346
35. Mfcd24392996
36. Akos016010776
37. Akos037643760
38. Cs-0734
39. Db11428
40. Sb17478
41. As-35172
42. Hy-17034
43. Sy114102
44. Sy116126
45. Db-060542
46. Ft-0666307
47. Ft-0670775
48. Ft-0716677
49. D08165
50. (+/-)-4-(alpha,2,3-trimethylbenzyl)imidazole
51. Ab01566810_01
52. A863235
53. L000223
54. L001361
55. Q427179
56. (+)-4-[1-(2,3-dimethylphenyl)ethyl]-1h-imidazole
57. (rs)-4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole
58. Brd-a66563878-003-01-8
59. (+/-)-4-(.alpha.,2,3-trimethylbenzyl)imidazole
60. 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-, (+/-)-
61. 6918-06-5
| Molecular Weight | 200.28 g/mol |
|---|---|
| Molecular Formula | C13H16N2 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 2 |
| Exact Mass | 200.131348519 g/mol |
| Monoisotopic Mass | 200.131348519 g/mol |
| Topological Polar Surface Area | 28.7 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 205 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Analgesics, Non-Narcotic
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)
Adrenergic alpha-2 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
51
PharmaCompass offers a list of Medetomidine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Medetomidine manufacturer or Medetomidine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Medetomidine manufacturer or Medetomidine supplier.
PharmaCompass also assists you with knowing the Medetomidine API Price utilized in the formulation of products. Medetomidine API Price is not always fixed or binding as the Medetomidine Price is obtained through a variety of data sources. The Medetomidine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Medetomidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Medetomidine, including repackagers and relabelers. The FDA regulates Medetomidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Medetomidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Medetomidine supplier is an individual or a company that provides Medetomidine active pharmaceutical ingredient (API) or Medetomidine finished formulations upon request. The Medetomidine suppliers may include Medetomidine API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Medetomidine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Medetomidine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Medetomidine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Medetomidine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Medetomidine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Medetomidine suppliers with NDC on PharmaCompass.
Medetomidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Medetomidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Medetomidine GMP manufacturer or Medetomidine GMP API supplier for your needs.
A Medetomidine CoA (Certificate of Analysis) is a formal document that attests to Medetomidine's compliance with Medetomidine specifications and serves as a tool for batch-level quality control.
Medetomidine CoA mostly includes findings from lab analyses of a specific batch. For each Medetomidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Medetomidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Medetomidine EP), Medetomidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Medetomidine USP).
